Early research (Phase 1)Not Yet RecruitingNCT07589400
What this trial is testing
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B
Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver DiseaseChronic Hepatitis b
Xiamen Amoytop Biotech Co., Ltd. 24